Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2017

01-12-2017 | Hepatobiliary Tumors

Comment on “Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases”: A Reply

Authors: Isamu Hosokawa, MD, PhD, Marc-Antoine Allard, MD, Gabriella Pittau, MD, Masaru Miyazaki, MD, PhD, René Adam, MD, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2017

Login to get access

Excerpt

We read with interest the letter of Cucchetti et al. regarding our article published in Annals of Surgical Oncology,1 and thank the authors for their suggestions and comments. …
Literature
1.
Hosokawa I, Allard MA, Gelli M, et al. Long-term survival benefit and potential for cure after R1 resection for colorectal liver metastases. Ann Surg Oncol. 2016; 23:1897–1905.CrossRefPubMed
2.
Cucchetti A, Ferrero A, Cescon M, et al. Cure model survival analysis after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2014; 19:1602–1608.
3.
Oba M, Hasegawa K, Matsuyama Y, et al. Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure. Ann Surg Oncol. 2014; 21:1817–1824.CrossRefPubMed
4.
Adam R, Wicherts DA, de Haas RJ, et al. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol. 2009; 27:1829–1835.CrossRefPubMed
Metadata
Title
Comment on “Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases”: A Reply
Authors
Isamu Hosokawa, MD, PhD
Marc-Antoine Allard, MD
Gabriella Pittau, MD
Masaru Miyazaki, MD, PhD
René Adam, MD, PhD
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6123-9

Other articles of this Special Issue 3/2017

Annals of Surgical Oncology 3/2017 Go to the issue

Gynecologic Oncology

Comment on: Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

Head and Neck Oncology

Reply to: Partial Verification Distorts Estimates of Sensitivity in Diagnostic Accuracy Studies for Fine-Needle Aspiration Cytology

Health Services Research and Global Oncology

Thank You to Annals of Surgical Oncology Expert Reviewer Community

Breast Oncology

Comparison of Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-Stage Breast Cancer

Breast Oncology

Comment on “Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy”

Hepatobiliary Tumors

Yes-Associated Protein (YAP) is a Key Factor for Improving the Management of Cancer Treatments